Cipla, Ltd. · 66-66 · INDIA
For Cipla, Ltd. · 66-66 · INDIA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is INDIA; product is Finasteride API; product code is 64 U C S 06 Finasteride (Inhibitor (Decarboxylase)), Human - Rx/Single Ingredient, Active Pharm Ingred/Chems for Further Manuf; date published is 10/18/2010; address is Plots D-7, D-22, D-27 , M.I.D.C. Industrial Area, Taluka-Daund , Kurkumbh Village, Dist. Pune, Maharashtra INDIA, verified against its source on 2026-09-16.
- Firm
- Cipla, Ltd. verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- INDIA verified
- Address
- Plots D-7, D-22, D-27 , M.I.D.C. Industrial Area, Taluka-Daund , Kurkumbh Village, Dist. Pune, Maharashtra INDIA verified
- Date published
- 10/18/2010 verified
- Product code
- 64 U C S 06 Finasteride (Inhibitor (Decarboxylase)), Human - Rx/Single Ingredient, Active Pharm Ingred/Chems for Further Manuf verified
- Product
- Finasteride API verified
What the source says
Cipla, Ltd. Date Published : 10/18/2010 Plots D-7, D-22, D-27 , M.I.D.C. Industrial Area, Taluka-Daund , Kurkumbh Village, Dist. Pune, Maharashtra INDIA 64 U C S 06 Finasteride (Inhibitor (Decarboxylase)), Human - Rx/Single Ingredient, Active Pharm Ingred/Chems for Further Manuf Date Published: 10/18/2010 Desc: Finasteride API
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.